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ABSTRACT
GeneCards1 is an automatically mined database of
human genes that strives to create, along with
its auxiliary databases—GeneLoc, GeneNote and
GeneAnnot—the most inclusive resource of gene-
centered information of the human genome.
GeneTide, the Gene Terra Incognita Discovery
Endeavor (http://genecards.weizmann.ac.il/genetide/),
the newest addition to this family, is a transcrip-
tome-focused database which aims to enhance
GeneCards with additional expressed sequence tag
(EST)-based genes. This is achieved by comprehen-
sivelymapping.85%ofthe 5.6millionhumanESTs
currentlyavailableatdbESTtoknowngenesbymeans
of data mining and integration of genomic resources
including UniGene, DoTS, AceView and in-house
resources. GeneTide thus creates comprehensive
links between ESTs and GeneCards genes.
Furthermore, groups of unassociated transcripts
serve as a basis for defining novel EST-based
GeneCards Candidates (EGCs). These EGCs, nearly
25000 of which were defined in version 0.3 of
GeneTide, are further annotated with various
parameters, including splicing evidence and expres-
sion data extracted from the GeneNote database, to
determine their validity as possible de novo genes.
INTRODUCTION
GeneCards(http://bioinfo.weizmann.ac.il/genecards/)(1)isan
automated, integrated database of human genes, proteins and
associated phenotypes, which strives to provide a
comprehensive and concise human gene compendium. The
GeneCards suite of databases includes (i) GeneLoc (http://
genecards.weizmann.ac.il/geneloc/) (2), anexon-basedsystem
that integrates data from LocusLink (3) and Ensembl (4)
(which together with HUGO constitute the core of the Gene-
Cards gene set) to create a uniﬁed location for each gene; (ii)
GeneAnnot (http://genecards.weizmann.ac.il/geneannot/) (5),
which links Affymetrix GeneChip probe sets with GeneCards
genes, by aligning the probe sequences to transcripts; and (iii)
GeneNote (http://genecards.weizmann.ac.il/genenote/) (6),
the Gene Normal Tissue Expression project, which portrays
gene expression proﬁles in healthy human tissues using Affy-
metrixGeneChip experimentsaswellasserial analysisofgene
expression (SAGE) and electronic northern results. GeneNote
additionally offers gene-centered expression attributes such as
ﬁgurative expression proﬁles, novel tissue speciﬁcity indices
and classiﬁcation of binary patterns.
To date, gene resources are based mainly on full-length
mRNA sequences, and on genes predicted from genomic data.
Since sequencing full-length mRNA is both time consuming
and costly, the mRNA sequences for many genes are not yet
available. Although new genes are continuously being uncov-
ered via ongoing full-length sequencing projects (7), it appears
that numerous genes are still absent from major gene compen-
dia including GeneCards, HUGO, LocusLink and Ensembl.
Since the early 1990’s, high-throughput methods were able
to generate a substantial number (>5.6 million) of human
expressed sequence tags (ESTs) (8), which now offer the
most comprehensive window to the entire human transcrip-
tome, and to the genes coded within it. Unfortunately, given
their fragmentary nature (typically 400–600 bases) and
inaccurate information (1–3% sequencing errors) (9),
assigning each of these ESTs to a gene has been incomplete.
Previous and ongoing projects designed to address this pro-
blem, such as UniGene (http://www.ncbi.nlm.nih.gov/
UniGene) (10), AceView (http://www.aceview.org/) and
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doi:10.1093/nar/gki122DoTS (http://www.allgenes.org/), have employed different
strategies, which resulted in various gene collections exhibit-
ing only partial mutual overlap. The relevant counts are
106937 UniGene gene-oriented clusters (build 171),
652095 DoTS genes (release 8) and 269134 AceView
genes (build 34), many of which are singletons or contain
very few member transcripts; all vastly exceed recent esti-
mates of the true count of human genes (25000–40000)
(11). Only a small number of these clusters (for instance,
21638 out of 106937 in UniGene) are associated with
known genes; this leaves the majority of such clusters with
norelatedindexedgene. Further,noattempthasyet beenmade
to compare and integrate the different clusters created by the
various databases, or to settle the discrepancies among them.
Hence, an efﬁcient mechanism for integrating data from such
transcriptome-centered resources is clearly called for.
To this end we have developed GeneTide, a transcriptome-
focused automated system for determining association
between ESTs and GeneCards genes, as well as for the elu-
cidation of new putative genes based on EST clusters sup-
ported by expression data. This system is founded on the same
concept underlying GeneCards: to sift, merge and integrate
data retrieved from various external resources together with
in-house generated experimental results. GeneTide signiﬁ-
cantly decreases the number of previously unassociated
ESTs, improves the quality of microarray annotation and
offers a large number of new groups of transcripts
(  25000 in version 0.3 of GeneTide) as candidate genes
for further research.
RESULTS AND DISCUSSION
GeneTide is an automated data integration system, which
consists of two major phases (Figure 1). In the ﬁrst phase,
transcripts (ESTs and mRNAs) are associated with existing
GeneCards genes using a uniﬁed scoring scheme to help over-
come differences between resources. In the second phase, new
candidate genes are deﬁned based on the previously unasso-
ciated transcripts. These candidate genes are further annotated
and ranked in order to help focus one’s attention on those that
hold the greatest promise for discovering valid novel genes.
GeneTide, like other members of the GeneCards suite of data-
bases can be expected to be updated roughly on a quarterly
basis, synchronized with the NCBI and Ensembl databases
whenever possible.
Transcript-gene association
Data resources. For GeneTide’s ﬁrst phase, we retrieved
transcript clusters created by UniGene, DoTS and AceView,
and recorded gene associations (via LocusLink identiﬁer).
These identiﬁers were later used to link all of the transcripts
contained within each cluster to the corresponding GeneCards
gene.
Next, genomic locations for the transcripts, which were
obtained using BLAT (12), were downloaded from the
UCSC’s genome browser database (13) and compared with
data from GeneLoc. Genes with exons located at a genomic
region found by BLAT for a speciﬁc transcript were recorded.
In order to overcome the problem of unknown orientation for
some of the ESTs deposited into GenBank, UCSC’s polyInfo
program results were retrieved. This program checks for cano-
nical splice signals at the genomic location of ESTs that
undergo splicing according to their BLAT alignment, and
determines the most probable alignment orientation of the
EST accordingly. Finally, transcripts that served as a basis
for deriving Affymetrix GeneChip HGU95A-E probe sets
were associated with GeneCards genes according to the
GeneAnnot annotation of such probe sets.
Figure 1. GeneTide workflow. Transcripts are either associated with known genes, used to define EST-based GeneCards Candidates (EGCs), or discarded as
artifacts.
Nucleic Acids Research, 2005, Vol. 33, Database issue D557Transcript validation. In order to assess the probability that
transcripts are genuine gene products rather than some geno-
micartifact orcontamination, a‘validation level’rangingfrom
0 (lowest) to 4 (highest) is assigned to each transcript. A point
is deducted from the transcript’s initial maximum for each of
the resources (UniGene, DoTS and AceView) that ﬁltered out
the transcript according to its own validation criteria. An addi-
tional point is deducted if a repetitive element was identiﬁed
by RepeatMasker along the transcript. The distribution of the
validation level among GeneTide’s transcripts is offered in the
Supplementary Material.
Integration and scoring scheme. The various gene annotations
obtained for each transcript from the ﬁve afore-mentioned
sources (UniGene, DoTS, AceView, BLAT and GeneLoc,
and GeneAnnot) were integrated into a single scoring scheme,
which ranks possible gene annotations by quality. Consensus
(Co)(1) and Uniqueness(Uq) (2), bothranging from 0to 1, are
deﬁned for a pair (E,G), where E is an EST and G is a Gene-
Cards gene as follows:
Co E,G ðÞ =
Nresources E,G ðÞ
Ntotal resources
, 1
Uq E,G ðÞ =
P
R2resources annotating E
WR
Ngenes assigned to E by R
  
P
R2resources annotating E WR
, 2
where Nresources(E,G) is the number of resources supporting the
annotationofEasderivedfromG,andWRisaweight assigned
to each of the resources according to quality considerations.
An integrative value (Score) designed to collapse these two
previous parameters into one, ranging from 0 to 1 was deﬁned
as follows:
Score E,G ðÞ =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Co2 + Uq2
2
s
: 3
Finally, the gene that achieved the highest score among all
related genes was deﬁned as the gene from which the EST
originated. More than 4.8 million transcripts out of an initial
number of nearly 5.6 million were associated in this manner to
27832 GeneCards genes in GeneTide’s version 0.3. This is a
signiﬁcant increase in both quantity (Figure 2) and quality of
association, between transcripts and genes, in comparison to
any of the other individual projects, which we attribute to the
unique integrative nature of GeneTide.
Microarray annotation. An immediate application of Gene-
Tide is deﬁning the gene of origin for microarray probe sets.
Affymetrix (www.affymetrix.com) probe sets are short
subsequencesderived fromtranscriptsforthepurposeofdeﬁn-
ing tags for those transcripts in hybridization experiments.
Unfortunately, in many cases, the identity of the gene remains
unknown, rendering the valuable experimentalexpression data
devoid of its genetic context. In order to overcome this
problem, we annotated probe sets with the same gene origin
as given by GeneTide (via the process described above) to the
transcripts from which they were derived. In a speciﬁc
example (Figure 3), this has allowed us to increase by nearly
50% (from 30912 to 46185 out of the entire set of 62667
probe sets) the number of Affymetrix HGU95A-E probe
sets annotated in comparison with previous attempts by
GeneAnnot version 0.3.
(a)
(b)
Figure 2. Association between transcripts and genes. GeneTide maps
 4.8 million transcripts (a) to 27832 genes (b). This is a significant
increase in the number of associated transcripts and genes in comparison to
UniGene, DoTS and AceView according to information extracted from their
respective websites.
Figure 3. Annotation of Affymetrix 62667 probe sets on GeneChip arrays
U95A-E. GeneTide has been able to increase the number of probe sets with an
assigned putative gene origin by  50% in comparison to other resources.
Another 5% of the probe sets have been retracted from UniGene (where
they were originally taken from) since the production of the U95 set.
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For the purpose of deﬁning de novo genes, non-singleton sets
of transcripts found to belong to the same cluster by all sources
and not associated previously with a known GeneCards gene,
were deﬁned as EST-based GeneCards Candidates (EGCs)
(Figure 1, bottom). Altogether, 25000 EGCs were deﬁned,
and associated with 110000 transcripts in GeneTide.
To distinguish the bona ﬁde novel genes from other possible
sources of EGCs, such as artifacts or exons of known genes,
we have taken the EGCs through an additional phase of anno-
tation. To assess the probability of a certain EGC representing
a valid gene rather than being an artifact, several parameters
were considered. These include the number of transcripts the
EGC is composed of (n), and the number of them which
undergo splicing (s) or contain repetitive elements (r)—infor-
mation extracted from the UCSC genome browser database.
Expression patterns of probe sets, derived from transcript
members of EGCs, retrieved from the GeneNote database,
helped to conﬁrm the validity of the transcribed sequences,
and focus attention on the tissues where these putative genes
are most likely expressed; they also provide initial insight
into its possible function. The number of derived probe sets
found by the GeneNote project to be expressed is denoted (x).
All these parameters were integrated into a single Validity
function V (4).
Vn ,s,r,x ðÞ =
ﬃﬃﬃ
n
p
· 0:5 +
s
n
  
  1:5  
r
n
  
· 2
ﬃﬃ
x
p
: 4
Taking into account the possibility that many of the EGCs
may constitute previously unidentiﬁed exons of known genes,
the average distance (d) of the transcripts constituting the EGC
from their nearest known gene was also noted. In order to
determinewhethertheresulting distanceistypicalofanintron,
the distribution of intron length (of 185175 introns from
26602 LocusLink genes included in GeneCards version
v2.30, which corresponds to NCBI build #34) was analyzed
(see Supplementary Material). The analysis shows that human
introns in general tend to be short, so the probability that an
EGC is an exon of its neighboring gene decreases as the dis-
tancefrom thatgene increases.Toquantifythis,we deﬁned the
Novelty function N(d) to be the percentage of introns in the
above mentioned dataset that are shorter than the distance to
the nearest known gene (d).
The product of the Validity of an EGC and its Novelty was
deﬁned as the Quality of the EGC. These quality values pro-
vide an efﬁcient manner for highlighting those EGCs (see
Supplementary Material for the distribution of the quality
score across EGCs) which hold the greatest potential to be
Figure4.EGC10294displayedonUCSC’sgenomebrowser.TheEGCislocatedontheplusstrandofchromosome7atthegenomicregionof20.001–20.007Mb,ina
region where no LocusLink, Ensembl or GeneCards gene is known. The graphic display shows the genomic location of EGCs along with predicted transcription
orientations,andisavailableforeachEGCviaGeneTide’swebsitealongwithatrackofallcurrentlyknownGeneCardsgenes.Thisdisplaywasmadepossiblethanks
to UCSC’s custom track mechanism (http://genome.ucsc.edu/goldenPath/help/customTrack.html).
Nucleic Acids Research, 2005, Vol. 33, Database issue D559new genes—a higher score indicating a higher likelihood of
being a genuine gene. Lower scoring EGCs might turn out
to be either alternative exons of known genes or artifacts/
contaminations.
An example for a high scoring EGC is EGC10294, one
of the top ﬁve scoring EGCs in GeneTide (e.g. see EGCs at
http://genecards.weizmann.ac.il/genetide/example_EGC.html),
which consists of 87 ESTs, 68 of which have known splice
sites. This EGC was constructed from UniGene, DoTS and
AceView gene clusters Hs.59203, DG.55117 and ‘roky’,
respectively. The EGC is located on the plus strand of chro-
mosome 7 at the genomic region of 20.001–20.007 Mb, and
the structure delineated by the underlying multiple ESTs exhi-
bitsaclearpatternofintronsandexons (Figure4).Theaverage
distance of the ESTs of this EGC to the nearest known gene on
the same strand (ITGB8) is 109427 bp, which corresponds to a
very low probability of 0.01 (calculated by using the Novelty
function) of this EGC being an exon of the known gene. In
addition, the U95 probe set 53201_at derived from the EST
AI928513 exhibits an expression pattern in which it is highly
expressed in the kidney and pancreas, moderately expressed in
the lung and spleen and expressed in a lower level in the
remaining tissues. This EGC is also supported by independent
gene predictions by TIGR (human_THC1807481) and par-
tially by Ensembl EST genes (ENSESTG00000015877).
In another example, EGC24125, a cluster of 72 transcripts,
62 of which have splice sites, aligned on the plus strand of
chromosome 6 at the genomic location of 126.47–126.64 Mb.
These transcripts are contained in each of the following gene
oriented clusters—UniGene cluster Hs.35962, DoTS gene
DG.73559 and AceView gene ‘garjer’, but are nevertheless
not associated with any of the genes in GeneCards, LocusLink
or Ensembl. Gene predictions corresponding to this EGC were
independently conﬁrmed by other EST-based gene prediction
projects such as Ensembl’s Vega (EM: Em:AC020559.3) and
EST gene (ENSESTG00000003851). Several other EGCs
deﬁned in this genomic region appear to be the result of alter-
native transcripts of the predicted gene. The nearest known
gene to this EGC is nearly 300000 bp away, making the
probability very low that this is one of its exons. In addition,
one of the ESTs—accession W55924, which had a U95 probe
set (51263_at) derived from it, exhibits, according to Gene-
Note data, an immune system speciﬁc expression pattern,
since it is highly expressed in the thymus and bone marrow,
but not expressed in any of the other tissues. This expression
data offers initial insight as to the possible function of the
suggested EGC, information that will facilitate future
examinations of this putative gene.
GeneTide website
The GeneTide website offers extensive detailed information
regarding queried transcripts. This information includes the
gene associations of a transcript according to a variety of
resources as described above (Figure 5). In addition, the geno-
mic location of the transcript as well as the genes that reside in
the same or nearest area are presented. Queries submitted to
theGeneTidedatabaseinclude Affymetrixprobesetidentiﬁers
(currently GeneChips U95 and U133 are supported), which
resultinalltheinformation related tothetranscriptfromwhich
the queried probe set was derived.
A batch query mechanism incorporated into GeneTide
allows for querying a large number of ESTs simultaneously,
by uploading a list of ESTs to the site. The result is a table of
highest scoring GeneCards genes associated with each tran-
script, or the identity of an EGC in which the transcript is
Figure 5. Transcript query results in GeneTide. GeneTide provides detailed information regarding known genes that the queried transcript is associated with
accordingtoUniGene,DoTS,AceView,GeneAnnotandGeneLoc.Thisincludestheidentifieroftherelevantclusterineachresource,theGeneCardsidentifier(GC
ID)andsymbolalongwithhyperlinkstotheresources.AdditionalinformationavailableviaGeneTide’swebsiteforeachtranscriptincludesthevalidationlevelofthe
transcript, its genomic location, known splicing sites, existence of repetitive elements and neighboring genes.
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allows for uploading the list of all transcripts from which the
probe sets of a certain microarray were derived. These
transcripts are then associated by GeneTide to genes, an asso-
ciation which is transitively applied back to the probe sets.
From a gene-centered perspective, querying for a speciﬁc
GeneCards gene provides a list of all transcripts associated
with that gene ordered by the quality of the association, so that
the best matching sequences appear ﬁrst. These sequences are
also provided through the GeneCards website.
GeneTide’s website offers a list of all EGCs (Figure 6)
sorted by their quality, as described above. For each EGC,
details about the identity, genomic location and other
attributes of the contained transcripts, including expression
patterns of derived probe sets, are shown.
SUMMARY
GeneTide offers a signiﬁcant improvement, both in quantity
and in quality, of association between members of the human
transcriptome and the set of known genes. GeneTide’s website
provides an integrated resource of data regarding individual
transcripts as well as an efﬁcient means for microarray anno-
tation. In addition, GeneTide’s EGC concept offers an impor-
tant step toward elucidating a large number of novel genes.
Future plans for GeneTide include the addition of sources
such as Ensembl’s Vega and EST genes, TIGR and
STACKDB for both phases of associating transcripts with
known genes and deﬁning novel genes. Annotation of putative
genes will be further enhanced with the addition of expression
data from other databases besides GeneNote such as GNF.
Introduction of homology comparisons as well as validation
with other gene prediction programs are expected to boost
GeneTide’s performance even further. This will help to
diminish the terra incognita, toward making GeneCards a
truly comprehensive compendium of human genes.
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